| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.2M | +1258.6% |
| Cost of Revenue | $1.3M | — |
| R&D Expense | $32.7M | +66.0% |
| SG&A Expense | $40.2M | +117.0% |
| Operating Income | -$62.7M | +43.6% |
| Interest Expense | $230K | -65.4% |
| Pre-tax Income | -$60.5M | +45.0% |
| Income Tax | $0 | -100.0% |
| Net Income | -$60.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.0M | -73.8% |
| Short-term Investments | $133.5M | — |
| Accounts Receivable | $1.9M | — |
| Inventory | $1.9M | — |
| Current Assets | $180.0M | +19.0% |
| Total Assets | $184.2M | +16.7% |
| Current Liabilities | $18.8M | +23.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.6M | -121.4% |
| Capital Expenditures | $444K | +865.2% |
| Investing Cash Flow | -$132.9M | -628.3% |
| Financing Cash Flow | $72.6M | -48.8% |
| Free Cash Flow | -$50.1M | -122.9% |
| +45.0% |
| EPS (Basic) | -$2.69 | +78.3% |
| EPS (Diluted) | -$2.69 | +78.3% |
| Total Liabilities |
| $25.9M |
| +20.3% |
| Stockholders' Equity | $158.4M | +16.1% |